NYSE · TFX
Teleflex Incorporated
U.S. listed stock · USD15-minute delay
Find an instrument
- AppleAAPL · NASDAQResearch →
- MicrosoftMSFT · NASDAQResearch →
- NvidiaNVDA · NASDAQResearch →
- AmazonAMZN · NASDAQResearch →
- AlphabetGOOGL · NASDAQResearch →
- Meta PlatformsMETA · NASDAQResearch →
- TeslaTSLA · NASDAQResearch →
- JPMorgan ChaseJPM · NYSEResearch →
- ExxonMobilXOM · NYSEResearch →
- WalmartWMT · NASDAQResearch →
- S&P 500 IndexSPX · S&PResearch →
- Nasdaq 100 IndexNDX · NASDAQResearch →
- Dow Jones Industrial AverageDJI · Dow JonesResearch →
- Cboe Volatility IndexVIX · CboeResearch →
- U.S. Dollar IndexDXY · ICEResearch →
- VIX futuresVX1! · Cboe Futures ExchangeResearch →
- DAX futuresFDAX1! · EurexResearch →
- Euro Stoxx 50 futuresFESX1! · EurexResearch →
- E-mini S&P 500 futuresES1! · CMEResearch →
- E-mini Nasdaq 100 futuresNQ1! · CMEResearch →
- E-mini Dow futuresYM1! · CBOTResearch →
- E-mini Russell 2000 futuresRTY1! · CMEResearch →
- WTI crude oil futuresCL1! · NYMEXResearch →
- Natural gas futuresNG1! · NYMEXResearch →
- Gold futuresGC1! · COMEXResearch →
- Silver futuresSI1! · COMEXResearch →
- Euro FX futures6E1! · CMEResearch →
- Japanese yen futures6J1! · CMEResearch →
- BitcoinBTCUSD · BitstampResearch →
- EtherETHUSD · BitstampResearch →
- Research Any U.S. stock or ETF tickerResearch →
No matching names. Type a U.S. stock ticker (for example MU) to research it.
Loading price chart…
15-minute delay. Chart times and available timeframes are controlled by the provider.
Earnings
Earnings calendarEarnings announcement for TFX: Nov 05, 2026
Teleflex Incorporated Common Stock is expected to report earnings on 11/05/2026 before market open. The report will be for the fiscal Quarter ending Sep 2026. According to Zacks Investment Research, based on 3 analysts' forecasts, the consensus EPS forecast for the quarter is $1.92. The reported EPS for the same quarter last year was $3.67.
| Fiscal quarter end | Consensus EPS forecast | High | Low | Estimates |
|---|---|---|---|---|
| Sep 2026 | $1.92 | $2.04 | $1.80 | 3 |
| Dec 2026 | $2.07 | $2.14 | $1.99 | 2 |
| Mar 2027 | $2.46 | $2.51 | $2.40 | 2 |
| Jun 2027 | $2.63 | $2.75 | $2.51 | 2 |
Source: Nasdaq, based on Zacks Investment Research consensus estimates. Dates marked as expected may change.
News
RTTNews · Zacks · Fintel- RTTNews · Oct 22, 7:52 AM EDTTeleflex Wins FDA Breakthrough Designation For Temporary Coronary Vessel Support(RTTNews) – Teleflex Incorporated (TFX) announced that the U.S. Food and Drug Administration (FDA) has granted Breakthrough Device Designation (BDD) to its Freesolve Resorbable Magnesium Scaffold (RMS) for percutaneous coronary intervention (PCI).
- Zacks · Oct 15, 8:28 AM EDTNatera Gains 118.1% in a Year: What's Driving the Rally?NTRA shares surge 118.1% in a year, fueled by robust Signatera adoption, expanding test volumes and improving margins, despite competition and rising costs.
- RTTNews · Oct 12, 7:04 AM EDTTeleflex Completes Enrollment In BIOMAG-LL Study Of Longer Freesolve Resorbable Scaffolds(RTTNews) – Teleflex Incorporated (TFX) announced the completion of patient enrollment in the BIOMAG-LL Clinical Study, evaluating the safety and clinical performance of 35 mm and 40 mm Freesolve Resorbable Magnesium Scaffolds for treating long coronary lesions.
- Zacks · Oct 8, 9:39 AM EDTBruker Gains 66.3% in a Year: What's Driving the Rally?BRKR shares surge 66.3% in a year, fueled by strong demand in mass spectrometry and biopharma, despite restructuring challenges and currency headwinds.
- Zacks · Oct 7, 8:51 AM EDTCharles River Gains 75.8% in a Year: What's Driving the Rally?CRL shares have surged 75.8% in a year as RMS trends improve, AI-enabled testing expands and cash flow supports buybacks and investment.
- Zacks · Oct 7, 8:51 AM EDTReasons to Add Globus Medical Stock to Your Portfolio NowGMED gains musculoskeletal share on strong spine and trauma growth, while product innovation and a debt-free balance sheet support its appeal.
- Zacks · Oct 6, 10:40 AM EDTTFX or SONVY: Which Is the Better Value Stock Right Now?TFX vs. SONVY: Which Stock Is the Better Value Option?
- Zacks · Oct 6, 10:29 AM EDTIs It Prudent to Add Teleflex Stock to Your Portfolio Now?TFX's Vascular growth, Asia expansion and improved leverage support the outlook, but tariffs, input costs and margin pressure remain key risks.
- Zacks · Sep 30, 9:44 AM EDTBoston Scientific's MedSurg Diversification Bolsters Growth ProspectsBSX's MedSurg segment supports growth, with Endoscopy and Neuromodulation gains offsetting Urology challenges and portfolio gaps.
- Zacks · Sep 29, 2:57 AM EDTTeleflex (TFX) Soars 4.4%: Is Further Upside Left in the Stock?Teleflex (TFX) saw its shares surge in the last session with trading volume being higher than average. The latest trend in earnings estimate revisions could translate into further price increase in the near term.
- Fintel · Sep 28, 10:02 AM EDTB of A Securities Upgrades Teleflex to Buy from NeutralOn September 28, 2026, B of A Securities upgraded their outlook for Teleflex (NYSE:TFX) (LSE:0ADI) from Neutral to Buy.Teleflex Incorporated, based in the United States, operates primarily within the medical technology industry focusing on innovations that enhance clinical benefi
- Zacks · Sep 24, 11:46 AM EDTHere's Why You Should Hold QIAGEN Stock in Your Portfolio for NowQGEN's test menu expansion and strategic partnerships support growth, but cautious spending and competition may weigh on near-term gains.
Stories from Nasdaq.com, including Zacks, The Motley Fool and Barchart. They open on the publisher’s site; AiFs Market does not edit or endorse them.
Company profile
Loading company profile…
Financials
Loading fundamental data…
More headlines
More stories for Teleflex Incorporated from TradingView. Coverage varies.
Loading related news…
Quotes, charts, company information and headlines are supplied by TradingView. Data may be delayed or unavailable. This page is for market research and does not provide investment advice.